Statine derivatives for the treatment of Alzheimer's disease III

US7238774B2 · kind B2 · utility

Assignee

• Boehringer Ingelheim International GmbH · DE

Inventors

• Stefan Peters · Biberach an der Riß, DE
• Klaus Fuchs · Ingelheim am Rhein, DE
• Christian Eickmeier · Mittelbiberach, DE
• Werner Stransky · Gau-Algesheim, DE
• Cornelia Dorner-Ciossek · Ingelheim am Rhein, DE
• Sandra Handschuh · Biberach an der Riß, DE
• Herbert Nar · Ochsenhausen, DE
• Klaus Klinder · Oggelshausen, DE
• Marcus Kostka · Biberach, DE

Key dates

• Filing date: Nov 7, 2005
• Grant date: Jul 3, 2007
• Expiry date: Nov 7, 2025

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K38/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to a compound of the formula (I)wherein R1, R2, R3, R4, R5, R6, R7 and R8 are defined as in the specification and claims and to its use for treating or preventing Alzheimer's disease and other similar diseases.